Oncotelic Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	0.41	0.09	0.17	0.24	0.57	0.47
Cash & Short-Term Investments	0.41	0.09	0.17	0.24	0.57	0.47
Cash Growth	174.46%	-49.46%	-29.43%	-57.55%	19.99%	478.33%
Accounts Receivable	-	-	0.02	-	-	0.02
Other Receivables	0	0.02	-	0.02	0.02	-
Receivables	0	0.02	0.02	0.02	0.02	0.02
Prepaid Expenses	1.18	0.01	0.06	0.02	0.02	0.1
Restricted Cash	0.02	0.02	0.02	0.02	0.02	0.02
Total Current Assets	1.61	0.13	0.27	0.3	0.63	0.62
Property, Plant & Equipment	-	-	-	-	-	0.01
Long-Term Investments	22.65	22.65	22.65	22.64	-	-
Goodwill	2.79	2.79	5.99	12.07	21.06	21.06
Other Intangible Assets	-	-	-	-	0.82	1.97
Long-Term Deferred Charges	1.1	1.1	1.1	1.1	1.1	-
Total Assets	28.16	26.68	30.01	36.12	23.61	23.66
Accounts Payable	1.69	1.69	1.66	1.74	1.93	1.94
Accrued Expenses	1.22	1.09	1.12	1.11	1.57	1.19
Short-Term Debt	13.87	13.09	10.68	11.26	8.99	4.65
Other Current Liabilities	3.3	3.33	3.05	2.82	2.97	3.4
Total Current Liabilities	20.08	19.2	16.5	16.92	15.45	11.18
Long-Term Debt	-	-	1.9	-	-	-
Total Liabilities	20.08	19.2	18.4	16.92	15.45	11.18
Common Stock	4.39	4.07	3.99	3.92	3.75	0.91
Additional Paid-In Capital	43.77	42.22	41.66	41.42	35.22	32.49
Retained Earnings	-39.11	-38.04	-33.52	-25.93	-31.02	-21.63
Total Common Equity	9.05	8.25	12.13	19.41	7.96	11.77
Minority Interest	-0.97	-0.77	-0.52	-0.22	0.2	0.71
Shareholders' Equity	8.08	7.48	11.61	19.19	8.16	12.48
Total Liabilities & Equity	28.16	26.68	30.01	36.12	23.61	23.66
Total Debt	13.87	13.09	12.57	11.26	8.99	4.65
Net Cash (Debt)	-13.46	-13	-12.4	-11.02	-8.42	-4.18
Net Cash Per Share	-0.03	-0.03	-0.03	-0.02	-0.03	-0.05
Filing Date Shares Outstanding	440.78	408.29	399.68	392.87	378.63	91.26
Total Common Shares Outstanding	439.45	407.29	399.18	391.85	375.29	90.6
Working Capital	-18.47	-19.07	-16.23	-16.62	-14.83	-10.57
Book Value Per Share	0.02	0.02	0.03	0.05	0.02	0.13
Tangible Book Value	6.26	5.46	6.14	7.34	-13.93	-11.27
Tangible Book Value Per Share	0.01	0.01	0.02	0.02	-0.04	-0.12

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.